Aino Health AB (Publisher)
This English document is a translation of the original Swedish text. In case of discrepancies, the original Swedish text takes precedence.
Contract extension. Improved cash flow.
January to June 2024
• Net sales amounted to KSEK 12,230 (11,971).
• Profit/loss after financial items was -4,960 KSEK (-5,598)
• Earnings per share were SEK -0.1 (-0.1)
April to June 2024
• Net sales amounted to KSEK 6,236 (5,791).
• Profit/loss after financial items was -2,017 KSEK (-2,807)
• Earnings per share were SEK -0.0 (-0.1)
We continued to grow licenses and achieve good results with our customers in the second quarter, but the most important thing in the second quarter was product development and data analysis.
Our groundbreaking technology can now identify and present the root causes of sickness absence and employee productivity within businesses and organizations.
This will transform management practices across the globe by connecting employee performance, health, and productivity. With this data analytics module set to be rolled out more broadly in Q3, we are committed to helping our clients achieve long-term success by investing in the health and wellbeing of their employees. We believe this will not only increase productivity and profitability but also strengthen relationships within the organisation.
Aino has delivered significant value to its clients and their employees and is confident that the new data analytics will provide its clients with the tools to further improve performance while significantly improving the overall framework for managing employee performance both within the organisation and in stakeholder engagement.
I would like to take this opportunity to thank our shareholders for participating in our funding round, which is a good foundation for us to move confidently forward in the second half of the year. We will continue to work hard, both internally and with our partners, to attract new customers to our services in order to further increase our license numbers and improve our profitability.
The information contained herein is published by Aino Health AB (publ) in accordance with the EU Market Abuse Regulation. This information was published on behalf of Jyrki Eklund, CEO and Managing Director of Aino Health AB, on 16 August 2024 at 8:30 a.m. (Central European Time).
More Information
Jyrki Eklund
CEO Aino Health
Phone: +358 40 042 4221
inquiry
Aino Health AB (publ) is listed on the Nasdaq Stockholm First North Growth Market (ticker: AINO).
Certified Advisor
Carnegie Investment Bank AB (public)
For more information, please visit https://investors.ainohealth.com/certified-adviser/.
The story continues
About AINO HEALTH (Publishing)
Aino Health is a leading provider of Software as a Service solutions in corporate health management.
The company’s comprehensive SaaS platform and system of services makes health, well-being and safety an integral part of everyday work, reducing sick leave, lowering associated costs and increasing productivity and employee engagement to improve business outcomes. To learn more, visit ainohealth.com.
Attachments
